IOPtima Ltd. has developed the IOPtimate system, a unique CO2 laser-assisted system for the treatment of Glaucoma.
The IOPtimate system is intended to treat patients with primary Open-Angle Glaucoma (POAG) and Pseudo-Exfoliative Glaucoma (PEXG). Notwithstanding, IOPtima has already accumulated a very positive experience in combined surgeries (Cataract and Glaucoma).
In utilizing the properties of the CO2 laser, the IOPtimate system, thins the sclera wall via ablating surges at the Schlemm’s Canal area without penetrating the scleral wall, thereby reducing IOP by facilitating adequate, functional percolation of intra-ocular fluid from the eye through the remaining membrane in a simple and highly controlled and specific manner.
As infrared CO2 laser radiation is absorbed and blocked by water and aqueous solutions, it is therefore ineffective in ablating when applied over wet tissues, thus does not allow the procedure to penetrate the eye like other invasive procedures.
Therefore, the remaining thin scleral layer remains intact, without penetration into the eye, which is known to be the source of most ophthalmic surgery complications, adverse events and side effects.
The IOPtimate System Components:
The Laser & Control Unit.
The surgeon chooses the program parameters on the LCD touch-screen and initiates the laser operation.
The Scanner is connected to the control unit, attached to the microscope and operated by a foot-switch. By using a sophisticated system of servo-engines and optics, the scanner takes the laser beam and accurately ablates the sclera as per the pre-selected area and pattern.